| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/17/2009 | WO2009114681A2 Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy |
| 09/17/2009 | WO2009114579A2 Reducing/oxidizing activity of maternal urine as indicator of fetal gender related characteristics |
| 09/17/2009 | WO2009114543A2 Nucleic acid-based tests for prenatal gender determination |
| 09/17/2009 | WO2009114534A1 Multi-gene classifiers and prognostic indicators for cancers |
| 09/17/2009 | WO2009114532A2 Markers for diagnosis of pulmonary inflammation and methods related thereto |
| 09/17/2009 | WO2009114531A2 In vivo evolution of hydrogenases using a hydrogen-sensing system |
| 09/17/2009 | WO2009114506A2 Method to engineer mapk signaling responses using synthetic scaffold interactions and scaffold-mediated feedback loops |
| 09/17/2009 | WO2009114496A1 Density-based cell detection system |
| 09/17/2009 | WO2009114185A2 Methods and compositions for translational profiling and molecular phenotyping |
| 09/17/2009 | WO2009114182A1 Labeled reactants and their uses |
| 09/17/2009 | WO2009114083A2 Determinants of antiviral response |
| 09/17/2009 | WO2009113985A1 Genetic markers associated with response to antidepressants |
| 09/17/2009 | WO2009113944A1 Sampling kit |
| 09/17/2009 | WO2009113888A2 Method for determining reduced predisposition to cancer based on genetic profile |
| 09/17/2009 | WO2009113794A2 Methods for screening initial codons providing desired expression levels of proteins, and methods for tuning expression and production of recombinant proteins |
| 09/17/2009 | WO2009113779A2 Method for measuring chromosome, gene or specific nucleotide sequence copy numbers using snp array |
| 09/17/2009 | WO2009113771A1 Lung cancer detecting method using lung cancer specific methylation marker genes |
| 09/17/2009 | WO2009113758A1 Plasma biomarker tool for the diagnosis of liver cancer comprising liver carboxylesterase 1 and liver cancer screening method |
| 09/17/2009 | WO2009113709A1 Method of preparing dna fragment having sticky end |
| 09/17/2009 | WO2009113674A1 Diagnosis of bladder carcinoma |
| 09/17/2009 | WO2009113649A1 Antibody having an immune-enhancement function |
| 09/17/2009 | WO2009113628A1 Method of denaturing protein with enzymes |
| 09/17/2009 | WO2009113593A1 Method of detecting nucleic acid having target nucleotide sequence, probe set and method of distinguishing nucleic acids |
| 09/17/2009 | WO2009113580A1 Rna-selective hybridization reagent and utilization of the same |
| 09/17/2009 | WO2009113495A1 Liver cancer detection method using gene capable of being expressed in liver cancer-specific manner, and therapeutic and prophylactic agent for liver cancer |
| 09/17/2009 | WO2009113446A1 Skin whitening method and screening method for factors for skin wrinkle formation suppression and/or removal |
| 09/17/2009 | WO2009113303A1 Method for detection of methylcytosine using photoresponsive probe |
| 09/17/2009 | WO2009113295A1 C2orf18 as target gene for cancer therapy and diagnosis |
| 09/17/2009 | WO2009113249A1 Fertility restorer gene and fertility restoration method for cw-type male sterile cytoplasm of rice |
| 09/17/2009 | WO2009113070A1 Freeze-free method for storage of polypeptides |
| 09/17/2009 | WO2009112882A1 Snp biomarkers for alzheimer ' s disease |
| 09/17/2009 | WO2009112868A1 A thermostable dna polymerase from palaeocuccus helgesonii |
| 09/17/2009 | WO2009112867A1 A thermostable dna polymerase from palaeococcus ferrophilus |
| 09/17/2009 | WO2009112849A2 Drug response markers |
| 09/17/2009 | WO2009112833A1 Identification of orthologous genes |
| 09/17/2009 | WO2009112791A1 Fluorogenic peptides and their method of production |
| 09/17/2009 | WO2009112537A1 Detecting analytes |
| 09/17/2009 | WO2009112498A1 Surface attachment |
| 09/17/2009 | WO2009112283A1 Rapid method for identifying polypeptide-nucleic acid interactions |
| 09/17/2009 | WO2009112032A1 Target amplification and sequencing with primers comprising triplex forming monomer units |
| 09/17/2009 | WO2009111840A1 Enzymes and methods for degrading bipyridylium herbicides |
| 09/17/2009 | WO2009094312A3 Detection of gstp1 hypermethylation in prostate cancer |
| 09/17/2009 | WO2009094297A3 Improved reagent compositions for use in electrochemical detection |
| 09/17/2009 | WO2009089296A3 Animal management |
| 09/17/2009 | WO2009086005A3 Breed-specific haplotypes for polled phenotypes in cattle |
| 09/17/2009 | WO2009080849A3 Genetic markers for the prognosis of multiple sclerosis |
| 09/17/2009 | WO2009062083A3 Methods and compositions for antibody therapy |
| 09/17/2009 | WO2009048747A3 Candidate genes and blood biomarkers for bipolar mood disorder, alcoholism and stress disorder |
| 09/17/2009 | WO2009048282A3 Method and kit for diagnosis of hormonal skin aging |
| 09/17/2009 | WO2009031044A3 Ampk deficient animals, screening methods, and related therapeutics and diagnostics |
| 09/17/2009 | WO2009005651A3 Complement-mediated thrombophilic assay |
| 09/17/2009 | WO2001085908A9 Clasp-1 transmembrane protein |
| 09/17/2009 | US20090235395 Use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
| 09/17/2009 | US20090235387 Pea line 08560865 |
| 09/17/2009 | US20090235386 Pea line 08530757 |
| 09/17/2009 | US20090235385 Pea line 08550821 |
| 09/17/2009 | US20090235384 Pea line 08560899 |
| 09/17/2009 | US20090235374 Pea line 08530756 |
| 09/17/2009 | US20090235371 Diagnostic method |
| 09/17/2009 | US20090235370 Secreted luciferase for ex vivo monitoring of in vivo processes |
| 09/17/2009 | US20090234332 Artificial microvascular device and methods for manufacturing and using the same |
| 09/17/2009 | US20090234202 Method and compositions for highly sensitive detection of molecules |
| 09/17/2009 | US20090234101 Directed evolution of novel binding proteins |
| 09/17/2009 | US20090234011 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress |
| 09/17/2009 | US20090233985 Compositions and methods for inhibiting hiv infections by inhibiting lerepo4 and glipr |
| 09/17/2009 | US20090233982 Methyltransferases and Their Uses |
| 09/17/2009 | US20090233954 Methods and systems for prognosis of a patient's response to treatment of androgenetic skin disorders |
| 09/17/2009 | US20090233942 Genetic markers associated with response to antidepressants |
| 09/17/2009 | US20090233888 Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth |
| 09/17/2009 | US20090233871 Complexed polypeptide and adjuvant for improved vaccines |
| 09/17/2009 | US20090233866 Screening Methods And The Use Of Agents Identified Using The Same |
| 09/17/2009 | US20090233858 Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation |
| 09/17/2009 | US20090233855 Compounds and methods for modulating activation of nf-kb |
| 09/17/2009 | US20090233842 Fgf2-related methods for diagnosing and treating depression |
| 09/17/2009 | US20090233840 Modified Dynorphin Expression in Animals and Identification of Compounds for Treatment of Obesity and Diabetes |
| 09/17/2009 | US20090233808 Compounds displayed on replicable genetic packages and methods of using same |
| 09/17/2009 | US20090233807 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators |
| 09/17/2009 | US20090233806 Protein isolation and analysis |
| 09/17/2009 | US20090233804 Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids |
| 09/17/2009 | US20090233803 Chromogenic in situ hybridization methods, kits, and compositions |
| 09/17/2009 | US20090233379 Taste Receptors Of The T1R Family From Domestic Dog |
| 09/17/2009 | US20090233330 Method and apparatus for measuring changes in cell volume |
| 09/17/2009 | US20090233329 Microfluidic chamber assembly for mastitis assay |
| 09/17/2009 | US20090233328 Method for reading images, in particular for studying the development of biofilm in a culture medium |
| 09/17/2009 | US20090233327 Surface Modification in a Manipulation Chamber |
| 09/17/2009 | US20090233326 Method for induction of the differentiation of visceral fat cell |
| 09/17/2009 | US20090233325 Screening method of nesfatin-1-action regulating substance or nesfatin-1-like action substance with the use of receptor protein selected from the group consisting of gpr3, gpr6 and gpr12 |
| 09/17/2009 | US20090233324 Methods for Diagnosing Cancer Using Samples Collected From A Central Vein Location or an Arterial Location |
| 09/17/2009 | US20090233323 Method for analysis of nkt cell function |
| 09/17/2009 | US20090233322 Colorimetric method and reagent used for the same |
| 09/17/2009 | US20090233321 Reducing/Oxidizing Activity of Maternal Urine As Indicator of Fetal Gender Related Characteristics |
| 09/17/2009 | US20090233320 from plankton Metridia pacifica; blue luminescence |
| 09/17/2009 | US20090233319 Method for Evaluating Skin Condition Using Squamous Cell Carcinoma Antigen as Marker |
| 09/17/2009 | US20090233316 Protein, An Antibody and Measurement of the Protein |
| 09/17/2009 | US20090233311 receptor binding assay; analysis and determining the level of procalcitonin in blood wherein an increased level of procalcitonin compared to healthy individuals is indicative of sepsis |
| 09/17/2009 | US20090233309 Biological specimen collection/transport compositions and methods |
| 09/17/2009 | US20090233308 quantitative of nucleic acid comprising conducting a nucleic acid polymerization in a solution comprising a nucleic acid as a template, a fluorescent dye, a nucleotide monomer labeled with an acceptor fluorescent dye and a synthetase enzymes, then measuring the change in an optical character |
| 09/17/2009 | US20090233307 Methods for detection of single strand breaks in dna |
| 09/17/2009 | US20090233306 diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome; biomarker consisting of between 3 and 35 different nucleic acid probe sets |
| 09/17/2009 | US20090233305 diagnosing whether a subject is likely to have inflammatory bowel disease (IBD) by detecting formation of hybridization complexes between the 2 or more probe sets and nucleic acid targets in the nucleic acid sample |